Drug profile · INN
chenodeoxycholic acid
CHENODEOXYCHOLIC ACID LEADIANT (PREVIOUSLY CHENODEOXYCHOLIC ACID SIGMA-TAU)
chenodeoxycholic acid (CHENODEOXYCHOLIC ACID LEADIANT (PREVIOUSLY CHENODEOXYCHOLIC ACID SIGMA-TAU)) is a bile acid receptor fxr agonist.
Drug details — chenodeoxycholic acid
- Class
- Alimentary tract and metabolism (A05)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
chenodeoxycholic acid (CHENODEOXYCHOLIC ACID LEADIANT (PREVIOUSLY CHENODEOXYCHOLIC ACID SIGMA-TAU)) is a bile acid receptor fxr agonist.
Key facts
Mechanism of action
Bile acid receptor FXR agonist
Primary target: Bile acid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is chenodeoxycholic acid?
chenodeoxycholic acid (CHENODEOXYCHOLIC ACID LEADIANT (PREVIOUSLY CHENODEOXYCHOLIC ACID SIGMA-TAU)) is a bile acid receptor fxr agonist.
What is the brand name for chenodeoxycholic acid?
CHENODEOXYCHOLIC ACID LEADIANT (PREVIOUSLY CHENODEOXYCHOLIC ACID SIGMA-TAU) is a marketed brand name for chenodeoxycholic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.